PFTs consist of:
1) Spirometry
2) Lung volumes
3) Diffusion capacity
# Spirometry
![](_attachments/Pasted%20image%2020231010180725.png)
# Stepwise Approach to PFTs
![](_attachments/Pasted%20image%2020231010180742.png)

![](_attachments/Pasted%20image%2020231010181550.png)
## Flow-Volume Loops
![](_attachments/Pasted%20image%2020231010180852.png)
![](_attachments/Pasted%20image%2020231010180859.png)

Extrathoracic --> inspiratory defect
Intrathoracic --> expiratory defect
Fixed --> inspiratory and expiratory defect

## Cutoff Values
| Severity  |FEV1 (% predicted)   |
|---|---|
|Mild|> 70|
|Moderate|60 – 69|
|Moderately Severe|50 – 59|
|Severe|35 – 50|
|Very Severe|< 35|

| Severity | DLCO (% predicted) |
| -------- | ------------------ |
| Mild     | > 60 and < LLN     |
| Moderate | 40 – 60            |
| Severe   | < 40               |

| Other                          |                              |
| ------------------------------ | ---------------------------- |
| Bronchodilator Response (FEV1) | > 200 mL AND 12%             |
| Hyperinflation                 | TLC > 120% predicted or >ULN |
| Gas Trapping                   | RV > 120% predicted or >ULN  |
## Diffusion Capacity
*Low DLCO:* Anemia, recent smoking, parenchymal lung disease, [pulmonary hypertension](Pulmonary%20Hypertension.md).
*Isolated low DLCO:* Consider anemia, smoking, early ILD
*High DLCO:* Obesity, alveolar hemorrhage, polycythemia, [asthma](Airway%20Disease/Allergic%20Asthma.md)

# References
1. University of Washington Practive PFTs
2. [2005 ATS "Interpretative strategies for lung function tests"](https://www.thoracic.org/statements/resources/pft/pft5.pdf)
